tweetindex
ES

JAMA Internal Medicine

@JAMAInternalMed · Chicago, IL · joined 07 Jul 2009

JAMA Internal Medicine is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

109 504Followers
478Following
30 467Posts total
9.7KViews on collected posts

Últimas publicaciones

📝 Thinking about submitting your #ESCCongress research to @JAMA_current, @JAMACardio or another JAMA Network journal? 🎥 This video walks you through what to expect from the submission and peer‑review process. https://t.co/gE26I45Txz 2.9K views · 0 likes · 0 reposts · 0 replies Open on X →
@JAMA_current 📊 Research Summary: In patients undergoing #TranscatheterAorticValveImplant, factor Xa inhibitor non-vitamin K antagonist oral anticoagulant monotherapy was noninferior to acetylsalicylic acid for bleeding, thromboembolic events, and all-cause death. https://t.co/ 429 views · 0 likes · 0 reposts · 0 replies Open on X →
Presented at #ESCCongress from @JAMA_current: After #TranscatheterAorticValveImplant, factor Xa inhibitor non–vitamin K antagonist oral anticoagulant monotherapy reduced hypoattenuated leaflet thickening vs acetylsalicylic acid monotherapy. https://t.co/PTbVmgxHsx https://t.co 2K views · 4 likes · 5 reposts · 1 replies Open on X →
🧵 Presented today at #ESCCongress from @JAMA_current: Among patients with persistent #AFib and significant low-voltage zones, adjunctive low-voltage zone ablation improved 12-month arrhythmia-free survival vs pulmonary vein isolation alone. https://t.co/hfmEH1u5UT https://t.co 1.4K views · 4 likes · 0 reposts · 1 replies Open on X →
Presented today at #ESCCongress from @JAMA_current: Meta-analysis: In #TransthyretinAmyloidCardiomyopathy, transthyretin gene silencers reduced all-cause mortality and recurrent cardiovascular events vs placebo. https://t.co/JguWrDPu7t https://t.co/fxvUu3C00J 1.4K views · 0 likes · 0 reposts · 0 replies Open on X →
✨ At #ESCCongress? Meet @JAMACardio Editor Barbara Casadei at booth K410 in the Publishers' Area today, Sunday, August 30, from 2:30-3:00 PM. 🌟Stop by to ask questions, discuss your research, and learn about publishing opportunities with the JAMA Network. https://t.co/BNYUAu 1.5K views · 0 likes · 0 reposts · 0 replies Open on X →

Frente a cuentas del mismo tamaño

6 publicaciones de los últimos 90 días, junto al rango de 100K–1M seguidores. justo en la mediana de su rango de seguidores.

Visualizaciones medianas1 464esta cuenta5 983mediana de 100K–1M
Alcance, %1.34%esta cuenta1.49%mediana de 100K–1M
Interacción, %0.00%esta cuenta0.93%mediana de 100K–1M
MétricaEsta cuentaMediana de 100K–1MProporción
Visualizaciones medianas por publicación1 4645 9830.24×
Alcance (visualizaciones ÷ seguidores)1.34%1.49%0.90×
Tasa de interacción0.00%0.93%0.00×

Otras cuentas de este rango →   Comparar con otra cuenta →   Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.5K30 Aug
1.4K
1.4K
2K
429
2.9K31 Aug

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.00%30 Aug
0.00%
0.35%
0.49%
0.00%
0.00%31 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes44.4%8 in total
Reposts27.8%5 in total
Replies11.1%2 in total
Bookmarks16.7%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Cuentas similares